Rivaroxaban Granule, For Suspension
Product Images NDC 67877-882

Product Visual Gallery

This gallery contains 33 technical images submitted to the FDA as part of the official labeling for Rivaroxaban (NDC 67877-882). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Riv-cart-u-1 (Riv Cart U 1)

This is a description of a medication called Rivaroxaban for Oral Suspension, with a recommended dosage of 1 mg/m when reconstituted. The text provides instructions on how pharmacists should reconstitute the medication before dispensing and emphasizes counseling caregivers on proper use. It also highlights the importance of storing the medication correctly, administering the dose by an adult caregiver, and providing a Medication Guide to each patient. The text includes details on the contents of the package, storage instructions, and a website for additional instructions for use. Additionally, it mentions manufacturing and distribution information for the product.*

FDA Label Image

Riv-fig-ifu1-u-b (Riv Fig Ifu1 U B)

FDA Label Image

Riv-fig-ifu10-u (Riv Fig Ifu10 U)

This is a useful tip for using a bottle of liquid medication. It emphasizes the importance of avoiding shaking the bottle too fast to prevent foaming, as this can result in an incorrect dosage being given. It is important to handle the bottle carefully to ensure accurate medication administration.*

FDA Label Image

Riv-fig-ifu11-u (Riv Fig Ifu11 U)

FDA Label Image

Riv-fig-ifu12-u (Riv Fig Ifu12 U)

FDA Label Image

Riv-fig-ifu13-u (Riv Fig Ifu13 U)

Use the oral dosing syringe provided with rivaroxaban for oral suspension to ensure accurate dosing.*

FDA Label Image

Riv-fig-ifu14-u-b (Riv Fig Ifu14 U B)

FDA Label Image

Riv-fig-ifu15-u (Riv Fig Ifu15 U)

This text provides dose measures for different quantities of liquid medication in milliliters. For example, 7.5mL is a mix of 5mL and 25mL, 10mL is a combination of 5mL and 5mL, 15mL consists of 5mL, 5mL, and 5mL, and 20mL is made up of 5mL, 5mL, 5mL, and 5mL.*

FDA Label Image

Riv-fig-ifu16-u (Riv Fig Ifu16 U)

FDA Label Image

Riv-fig-ifu17-u-b (Riv Fig Ifu17 U B)

FDA Label Image

Riv-fig-ifu18-u-b (Riv Fig Ifu18 U B)

FDA Label Image

Riv-fig-ifu19-u-b (Riv Fig Ifu19 U B)

FDA Label Image

Riv-fig-ifu2-u-b (Riv Fig Ifu2 U B)

FDA Label Image

Riv-fig-ifu20-1u (Riv Fig Ifu20 1u)

This message serves as a reminder to ensure you have an adequate supply of medication to complete the full dose prescribed. Avoid taking partial doses as it may not be effective or safe.*

FDA Label Image

Riv-fig-ifu21-u-b (Riv Fig Ifu21 U B)

FDA Label Image

Riv-fig-ifu22-u-b (Riv Fig Ifu22 U B)

FDA Label Image

Riv-fig-ifu23-u-b (Riv Fig Ifu23 U B)

FDA Label Image

Riv-fig-ifu24-u (Riv Fig Ifu24 U)

This text "Step 5: Give the dose" indicates that in a set of instructions or process, the fifth step involves administering a certain quantity of medication or substance. This step is crucial in providing the intended treatment or effect as prescribed.*

FDA Label Image

Riv-fig-ifu25-u-b (Riv Fig Ifu25 U B)

FDA Label Image

Riv-fig-ifu26-u (Riv Fig Ifu26 U)

This text provides instructions on how to administer a dose of medication using a syringe. It advises that if the dose is greater than 5 mL, the same syringe may need to be used multiple times, requiring the individual to repeat steps 4 and 5 to complete the required dose.*

FDA Label Image

Riv-fig-ifu27-u (Riv Fig Ifu27 U)

This text instructs the reader to rinse and store an item, likely as part of a set of steps in a process or procedure.*

FDA Label Image

Riv-fig-ifu28-u-b (Riv Fig Ifu28 U B)

FDA Label Image

Riv-fig-ifu29-u (Riv Fig Ifu29 U)

This is a safety warning advising against placing the oral dosing syringe in the dishwasher for cleaning. It is important to follow these instructions to avoid damage to the syringe or potential contamination of medication.*

FDA Label Image

Riv-fig-ifu3-u-b (Riv Fig Ifu3 U B)

FDA Label Image

Riv-fig-ifu4-u (Riv Fig Ifu4 U)

FDA Label Image

Riv-fig-ifu5-u (Riv Fig Ifu5 U)

FDA Label Image

Riv-fig-ifu6-u (Riv Fig Ifu6 U)

This appears to be a simple instruction related to food safety. The text advises to check the "Discard after" date, implying that the product should be discarded after that specified date to ensure freshness and safety.*

FDA Label Image

Riv-fig-ifu7-u (Riv Fig Ifu7 U)

FDA Label Image

Riv-fig-ifu8-u (Riv Fig Ifu8 U)

FDA Label Image

Riv-fig-ifu9-u (Riv Fig Ifu9 U)

FDA Label Image

Riv-fig2-u (Riv Fig2 U)

This text provides information regarding the Population Description PK Fold Change and 90% CI for different conditions such as End-Stage Renal Disease, Renal Impairment, Age groups, Body Weight categories, and Hepatic Impairment. It includes comparisons such as severe vs. normal renal impairment, different age groups, body weight categories, and levels of hepatic impairment, along with the associated fold change and 90% confidence intervals. The data appears to be related to the pharmacokinetics of rivaroxaban in specific patient populations, including those with end-stage renal disease and different degrees of renal and hepatic impairments.*

FDA Label Image

Riv-fig3-u (Riv Fig3 U)

FDA Label Image

Riva-str-u (Riv Str U)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.